Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology

Soon Thye Lim Department of Medical Oncology, National Cancer Centre, SingaporeCorrespondence[email protected]

Siew Wan Hee Department of Biostatistics and Clinical Epidemiology National Cancer Centre, Singapore

Richard Quek Department of Medical Oncology, National Cancer Centre, Singapore

Miriam Tao Department of Medical Oncology, National Cancer Centre, Singapore

References

Armitage J O, Potter J F. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. J Am Geriatr Soc 1984; 32: 269–273
PubMed Web of Science ®Google Scholar
Solal-Celigny P, Chastang C, Herrera A, Desaint B, Renoux M, Gaulard P, et al. Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma. Am J Med 1987; 83: 1075–1079
PubMed Web of Science ®Google Scholar
Dixon D O, Neilan B, Jones S E, Lipschitz D A, Miller T P, Grozea P N, et al. Effect of age on the therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295–305
PubMed Web of Science ®Google Scholar
Thieblemont C, Coiffier B. Lymphoma in older patients. J Clin Oncol 2007; 25: 1916–1923
PubMed Web of Science ®Google Scholar
Bairey O, Benjamini O, Blickstein D, Elis A, Ruchlemer R. Non-Hodgkin's lymphoma in patients 80 years of age or older. Ann Oncol 2006; 17: 928–934
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date